| 发明名称 |
3-METHYL-2- ( (2S) -2- (4- (3-METHYL-L, 2, 4-0XADIAZ0L-5-YL) PHENYL) MORPHOLINO) -6- (PYRIMIDIN-4-YL) PYRIMIDIN-4 (3H) -ONE AS TAU PROTEIN KINASE INHIBITOR |
| 摘要 |
<p>A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of tau protein kinase 1 such as a neurodegenerative diseases (e.g. Alzheimer disease).</p> |
| 申请公布号 |
WO2009035159(A1) |
申请公布日期 |
2009.03.19 |
| 申请号 |
WO2008JP66929 |
申请日期 |
2008.09.12 |
| 申请人 |
MITSUBISHI TANABE PHARMA CORPORATION;SANOFI-AVENTIS;SAKAI, DAIKI;WATANABE, KAZUTOSHI |
发明人 |
SAKAI, DAIKI;WATANABE, KAZUTOSHI |
| 分类号 |
C07D413/14;A61K31/5377;A61P25/00 |
主分类号 |
C07D413/14 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
